UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty

The journals of gerontology. Series A, Biological sciences and medical sciences, 2024-03, Vol.79 (3)

2024

Volltextzugriff (PDF)

No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

The Journal of infectious diseases, 2021-06, Vol.223 (11), p.1928-1933

2021

Volltextzugriff (PDF)

Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury

The Journal of infectious diseases, 2021-05, Vol.223 (9), p.1612-1620

2021

Volltextzugriff (PDF)

No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

The Journal of infectious diseases, 2021, Vol.223 (11), p.1928

2021

Volltextzugriff (PDF)

Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury

The Journal of infectious diseases, 2021, Vol.223 (9), p.1612

2021

Volltextzugriff (PDF)

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

Journal of antimicrobial chemotherapy, 2020-05, Vol.75 (5), p.1311-1320

2020

Volltextzugriff (PDF)

The significance of tryptophan metabolism and vitamin B-6 status in cardiovascular disease

The American journal of clinical nutrition, 2020-01, Vol.111 (1), p.8-9

2020

Volltextzugriff (PDF)

Cardioprotective effect of polyamine spermidine

The American journal of clinical nutrition, 2019-01, Vol.109 (1), p.218-218

2019

Volltextzugriff (PDF)

Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection

Clinical infectious diseases, 2018-11, Vol.67 (11), p.1697-1704

2018

Volltextzugriff (PDF)

205 Serum tryptophan and kynurenine levels are altered in systemic sclerosis patients and show distinct clinical and autoantibody associations suggesting potential role in pathogenesis

Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3)

2018

Volltextzugriff (PDF)

Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers

The Journal of infectious diseases, 2018-01, Vol.217 (1), p.69-81

2018

Volltextzugriff (PDF)

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy

The Journal of infectious diseases, 2017-04, Vol.215 (7), p.1132-1140

2017

Volltextzugriff (PDF)

Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study

The Journal of infectious diseases, 2016-12, Vol.214 (12), p.1822-1825

2016

Volltextzugriff (PDF)

Tryptophan Metabolism in Post-Withdrawal Alcohol-Dependent Patients

Alcohol and alcoholism (Oxford), 2014-05, Vol.49 (3), p.251-255

2014

Volltextzugriff (PDF)

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

The Journal of infectious diseases, 2013-06, Vol.207 (11), p.1703-1712

2013

Volltextzugriff (PDF)

Tryptophan Catabolism During Intracellular Infection

The Journal of infectious diseases, 2012-05, Vol.205 (10), p.1617-1618

2012

Volltextzugriff (PDF)

Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy

The Journal of infectious diseases, 2011-12, Vol.204 (12), p.1936-1945

2011

Volltextzugriff (PDF)

Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden

The Journal of infectious diseases, 2011-09, Vol.204 (5), p.753-760

2011

Volltextzugriff (PDF)

Reply to Seligman

The Journal of infectious diseases, 2011-07, Vol.204 (1), p.174-175

2011

Volltextzugriff (PDF)

Possibility of HIV-1 Resistance Mutations in Cerebrospinal Fluid From Persons Receiving Suppressive Therapy Reply

The Journal of infectious diseases, 2011, Vol.204 (1), p.174

2011

Volltextzugriff (PDF)

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

The Journal of infectious diseases, 2010-12, Vol.202 (12), p.1819-1825

2010

Volltextzugriff (PDF)

Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health Study

Clinical chemistry (Baltimore, Md.), 2009-06, Vol.55 (6), p.1135-1146

2009

Volltextzugriff (PDF)

Preexpanded Vertical Trapezius Musculocutaneous Flap for Reconstruction of a Severe Neck Contracture After Burn Injury

Journal of burn care & research, 2008-03, Vol.29 (2), p.386-389

2008

Volltextzugriff (PDF)

Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2007-12, Vol.196 (12), p.1779-1783

2007

Volltextzugriff (PDF)

A33scFv–Green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting

Protein engineering, design and selection, 2007-12, Vol.20 (12), p.583-590

2007

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(55)
magazinearticle
(1)

Sprache

Englisch
(56)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty

No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury

No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

The significance of tryptophan metabolism and vitamin B-6 status in cardiovascular disease

Cardioprotective effect of polyamine spermidine

Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection

205 Serum tryptophan and kynurenine levels are altered in systemic sclerosis patients and show distinct clinical and autoantibody associations suggesting potential role in pathogenesis

Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy

Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study

Tryptophan Metabolism in Post-Withdrawal Alcohol-Dependent Patients

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

Tryptophan Catabolism During Intracellular Infection

Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy

Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden

Reply to Seligman

Possibility of HIV-1 Resistance Mutations in Cerebrospinal Fluid From Persons Receiving Suppressive Therapy Reply

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health Study

Preexpanded Vertical Trapezius Musculocutaneous Flap for Reconstruction of a Severe Neck Contracture After Burn Injury

Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy

A33scFv–Green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting

Aktive Filter

Suchergebnisse filtern